Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-10-6
pubmed:abstractText
Topiramate was approved for the treatment of epilepsy in 1999 and has since been approved for the prevention of migraine headache. It is structurally different from the majority of antiepileptic medications and is pharmacodynamically unique in its ability to inhibit the enzyme carbonic anhydrase. Postmarketing reports of topiramate-associated hypothermia have occurred but this adverse event has not been well characterized. Data mining of an adverse event database was used to assist in the identification of hypothermia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1365-2710
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
513-9
pubmed:meshHeading
pubmed-meshheading:18834366-Adolescent, pubmed-meshheading:18834366-Adult, pubmed-meshheading:18834366-Adverse Drug Reaction Reporting Systems, pubmed-meshheading:18834366-Aged, pubmed-meshheading:18834366-Aged, 80 and over, pubmed-meshheading:18834366-Algorithms, pubmed-meshheading:18834366-Ammonia, pubmed-meshheading:18834366-Anticonvulsants, pubmed-meshheading:18834366-Bicarbonates, pubmed-meshheading:18834366-Child, pubmed-meshheading:18834366-Child, Preschool, pubmed-meshheading:18834366-Databases, Factual, pubmed-meshheading:18834366-Drug Interactions, pubmed-meshheading:18834366-Female, pubmed-meshheading:18834366-Fructose, pubmed-meshheading:18834366-Humans, pubmed-meshheading:18834366-Hypothermia, pubmed-meshheading:18834366-Male, pubmed-meshheading:18834366-Middle Aged, pubmed-meshheading:18834366-Retrospective Studies, pubmed-meshheading:18834366-United States, pubmed-meshheading:18834366-United States Food and Drug Administration, pubmed-meshheading:18834366-Valproic Acid, pubmed-meshheading:18834366-Young Adult
pubmed:year
2008
pubmed:articleTitle
Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
pubmed:affiliation
New Hope Cancer Center, Hudson, FL, USA. james.knudsen@fda.hhs.gov
pubmed:publicationType
Journal Article